ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 125 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,000 | +200.0% | 142 | +246.3% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 41 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | -83.3% | 41 | -70.9% | 0.00% | – |
| Q1 2019 | $6,000 | +500.0% | 141 | +235.7% | 0.00% | – |
| Q4 2018 | $1,000 | -50.0% | 42 | 0.0% | 0.00% | – |
| Q3 2018 | $2,000 | 0.0% | 42 | -4.5% | 0.00% | – |
| Q2 2018 | $2,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q1 2018 | $2,000 | +100.0% | 44 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 44 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | – | 44 | +100.0% | 0.00% | – |
| Q3 2016 | $0 | – | 22 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 22 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 22 | -53.2% | 0.00% | – |
| Q4 2015 | $1,000 | 0.0% | 47 | +88.0% | 0.00% | – |
| Q3 2015 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 1,000,000 | $3,280,000 | 10.95% |
| M28 Capital Management LP | 439,300 | $1,440,904 | 1.37% |
| Redmile Group, LLC | 6,242,756 | $20,476,240 | 0.84% |
| MAVERICK CAPITAL LTD | 6,291,013 | $20,634,523 | 0.49% |
| Baupost Group | 8,123,616 | $26,645 | 0.44% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 52,000 | $171 | 0.25% |
| WASATCH ADVISORS LP | 8,391,014 | $27,522,525 | 0.18% |
| PACIFIC HEIGHTS ASSET MANAGEMENT LLC | 525,000 | $1,722,000 | 0.17% |
| STALEY CAPITAL ADVISERS INC | 450,000 | $1,476 | 0.09% |
| Virtus ETF Advisers LLC | 36,100 | $118,408 | 0.06% |